Evgeny Zaytsev

Dr. Evgeny Zaytsev is a venture capitalist with more than twelve years’ investment experience in life sciences. Before joining RMI Partners (the management company for RusnanoMedInvest) he was a general partner at Helix Ventures (Palo Alto, California), which he co-founded to exclusively invest in novel therapeutic opportunities (biopharmaceuticals and medical devices). Prior to Helix Dr. Zaytsev was a partner of the venture capital pioneer Pitch Johnson at Asset Management Company, one of the oldest venture firms in Silicon Valley.

Dr. Zaytsev has been involved in more than 30 investments in biomedical companies, including such success stories of venture capital as BiPar Sciences (acquired by sanofi-aventis), Chimerix (NADSDAQ: CMRX), Enteric Medical Technologies (acquired by Boston Scientific), Fusion Medical Technologies (acquired by Baxter International), MicroVention (acquired by Terumo Corporation), TriVascular (acquired by Boston Scientific). He has been a Board Member of a number of companies in Silicon Valley and Russia.